Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for CGON

Stock Name	CG Oncology, Inc. Common stock
Ticker	CGON(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US1569441009

Show aggregate CGON holdings

News associated with CGON

CG Oncology (NASDAQ:CGON) Stock Price Expected to Rise, Morgan Stanley Analyst Says: CG Oncology (NASDAQ:CGON – Get Free Report) had its target price lifted by Morgan Stanley from $56.00 to $79.00 in a report issued on Wednesday, MarketBeat reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price target indicates a potential upside of 103.50% from the stock’s current price. CGON has been […] - 2025-09-19 02:36:47
CG Oncology (NASDAQ:CGON) Shares Gap Up on Insider Buying Activity: CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s share price gapped up prior to trading on Monday after an insider bought additional shares in the company. The stock had previously closed at $33.34, but opened at $35.10. CG Oncology shares last traded at $34.33, with a volume of 114,584 shares. Specifically, Director Brian Guan-Chyun Liu […] - 2025-09-17 02:12:49
CG Oncology (NASDAQ:CGON) Coverage Initiated at Jones Trading: Stock analysts at Jones Trading assumed coverage on shares of CG Oncology (NASDAQ:CGON – Get Free Report) in a research note issued to investors on Monday,Benzinga reports. The brokerage set a “buy” rating and a $50.00 price target on the stock. Jones Trading’s price objective points to a potential upside of 49.39% from the stock’s […] - 2025-09-10 02:40:50
Brokerages Set CG Oncology, Inc. (NASDAQ:CGON) Price Target at $54.30: Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy […] - 2025-09-09 02:29:01
CG Oncology (NASDAQ:CGON) Upgraded by Zacks Research to “Hold” Rating: Zacks Research upgraded shares of CG Oncology (NASDAQ:CGON – Free Report) from a strong sell rating to a hold rating in a research note published on Monday,Zacks.com reports. CGON has been the topic of a number of other research reports. Piper Sandler began coverage on CG Oncology in a report on Monday, August 18th. They […] - 2025-09-04 03:02:54
Analysts Set CG Oncology, Inc. (NASDAQ:CGON) Price Target at $55.30: Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have earned an average recommendation of “Buy” from the twelve research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating […] - 2025-08-15 02:24:52
CG Oncology, Inc. (NASDAQ:CGON) Receives $55.30 Average Target Price from Brokerages: CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) has been given an average recommendation of “Buy” by the twelve ratings firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating […] - 2025-07-21 02:30:49
Brokerages Set CG Oncology, Inc. (NASDAQ:CGON) PT at $58.67: Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have earned an average recommendation of “Buy” from the eleven research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation […] - 2025-06-26 02:23:03
CG Oncology (NASDAQ:CGON) Price Target Raised to $56.00: CG Oncology (NASDAQ:CGON – Get Free Report) had its target price hoisted by investment analysts at Morgan Stanley from $52.00 to $56.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 113.09% from the stock’s current price. […] - 2025-06-19 02:56:48
CG Oncology (NASDAQ:CGON) Trading Up 4.7% After Analyst Upgrade: CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s stock price traded up 4.7% during trading on Tuesday after Morgan Stanley raised their price target on the stock from $52.00 to $56.00. Morgan Stanley currently has an overweight rating on the stock. CG Oncology traded as high as $26.31 and last traded at $26.65. 213,112 shares […] - 2025-06-19 02:13:09
CG Oncology, Inc. (NASDAQ:CGON) Position Decreased by Nuveen Asset Management LLC: Nuveen Asset Management LLC decreased its holdings in shares of CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 27.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 111,716 shares of the company’s stock after selling 41,918 shares during the period. […] - 2025-06-02 04:58:49
ProShare Advisors LLC Acquires 7,599 Shares of CG Oncology, Inc. (NASDAQ:CGON): ProShare Advisors LLC boosted its holdings in CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 84.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,561 shares of the company’s stock after acquiring an additional 7,599 shares during the period. ProShare Advisors […] - 2025-05-27 06:37:07
Morgan Stanley Has Lowered Expectations for CG Oncology (NASDAQ:CGON) Stock Price: CG Oncology (NASDAQ:CGON – Get Free Report) had its price objective dropped by investment analysts at Morgan Stanley from $55.00 to $52.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price target indicates a potential upside of 95.78% from the stock’s current price. A […] - 2025-05-21 02:56:59
CG Oncology (NASDAQ:CGON) Shares Gap Down After Earnings Miss: CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s share price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously closed at $25.16, but opened at $24.21. CG Oncology shares last traded at $24.95, with a volume of 42,738 shares. The company reported ($0.45) earnings per share […] - 2025-05-15 02:18:49
CG Oncology, Inc. (NASDAQ:CGON) Receives $57.70 Consensus Price Target from Brokerages: Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have earned a consensus recommendation of “Buy” from the twelve analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, ten have issued a buy recommendation and one has issued a strong buy recommendation on the […] - 2025-05-07 02:19:09
CG Oncology, Inc. (NASDAQ:CGON) Shares Acquired by Wells Fargo & Company MN: Wells Fargo & Company MN grew its stake in CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 45.3% during the fourth quarter, HoldingsChannel reports. The firm owned 28,234 shares of the company’s stock after purchasing an additional 8,803 shares during the quarter. Wells Fargo & Company MN’s holdings in CG Oncology were worth $810,000 as […] - 2025-05-01 05:08:57
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 09:31:47
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 08:55:47
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 08:28:41
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 05:42:14
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 03:41:45
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 01:15:49
Stocks Mixed on Trade News and Chip Stock Weakness: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. June E-mini S&P futures (ESM25 ) are up +0.02%, and June E-mini Nasdaq futures... - 2025-04-28 19:59:34
Stocks Climb on Hopes of US Trade Deals: The S&P 500 Index ($SPX ) (SPY ) today is up +0.44%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. June E-mini S&P futures (ESM25 ) are up +0.41%, and June E-mini Nasdaq futures... - 2025-04-28 17:47:00
Stocks Mixed on Trade News and Chip Stock Weakness: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. June E-mini S&P futures (ESM25 ) are up +0.02%, and June E-mini Nasdaq futures... - 2025-04-28 14:54:49
Stocks Mixed on Trade News and Chip Stock Weakness: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. June E-mini S&P futures (ESM25 ) are up +0.02%, and June E-mini Nasdaq futures... - 2025-04-28 14:42:47
Stocks Mixed on Trade News and Chip Stock Weakness: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. June E-mini S&P futures (ESM25 ) are up +0.02%, and June E-mini Nasdaq futures... - 2025-04-28 14:28:17
Stocks Climb on Hopes of US Trade Deals: The S&P 500 Index ($SPX ) (SPY ) today is up +0.44%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. June E-mini S&P futures (ESM25 ) are up +0.41%, and June E-mini Nasdaq futures... - 2025-04-28 14:11:20
Legal & General Group Plc Acquires 2,793 Shares of CG Oncology, Inc. (NASDAQ:CGON): Legal & General Group Plc raised its position in CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 10.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 29,262 shares of the company’s stock after acquiring an additional 2,793 shares during the period. Legal & General Group Plc’s holdings in CG Oncology were worth $839,000 […] - 2025-04-28 05:02:55
Vanguard Group Inc. Boosts Stock Position in CG Oncology, Inc. (NASDAQ:CGON): Vanguard Group Inc. lifted its stake in CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 15.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 5,861,082 shares of the company’s stock after purchasing an additional 779,730 shares during the period. Vanguard Group Inc. owned approximately 0.08% of CG Oncology worth $168,096,000 as of its […] - 2025-04-07 04:41:00

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CGON holdings

Date	Number of CGON Shares Held	Base Market Value of CGON Shares	Local Market Value of CGON Shares	Change in CGON Shares Held	Change in CGON Base Value	Current Price per CGON Share Held	Previous Price per CGON Share Held
2025-09-26 (Friday)	9,858	USD 370,069	USD 370,069
2025-09-25 (Thursday)	9,858	USD 359,620	USD 359,620	0	USD -1,971	USD 36.48	USD 36.68
2025-09-24 (Wednesday)	9,858	USD 361,591	USD 361,591
2025-09-17 (Wednesday)	9,796	USD 369,505	USD 369,505	0	USD 19,200	USD 37.72	USD 35.76
2025-09-16 (Tuesday)	9,796	USD 350,305	USD 350,305
2025-09-12 (Friday)	9,734	USD 324,532	USD 324,532
2025-09-11 (Thursday)	9,734	USD 322,779	USD 322,779	124	USD -982	USD 33.16	USD 33.69

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CGON by Blackrock for IE00B3VWM098

Show aggregate share trades of CGON

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-11 BUY 124 33.160* 27.74
2025-08-21 SELL -31 25.980* 27.75 Profit of 860 on sale
2025-07-31 BUY 93 26.690* 27.77
2025-06-30 SELL -62 26.000* 27.93 Profit of 1,732 on sale
2025-06-25 SELL -31 26.060* 27.97 Profit of 867 on sale
2025-06-20 SELL -62 25.550* 28.02 Profit of 1,737 on sale
2025-05-30 BUY 6,715 25.620* 28.21
2025-05-23 BUY 9 25.440* 28.32
2025-05-19 SELL -9 24.860* 28.40 Profit of 256 on sale
2025-05-15 SELL -27 25.350* 28.45 Profit of 768 on sale
2025-05-12 SELL -9 25.160* 28.56 Profit of 257 on sale
2025-05-09 SELL -9 23.740* 28.60 Profit of 257 on sale
2025-04-30 SELL -9 26.940* 28.80 Profit of 259 on sale
2025-04-24 SELL -18 21.520* 28.96 Profit of 521 on sale
2025-04-17 SELL -9 20.640* 29.40 Profit of 265 on sale
2025-04-15 SELL -27 20.110* 29.60 Profit of 799 on sale
2025-04-14 SELL -27 20.060* 29.70 Profit of 802 on sale
2025-04-09 SELL -36 17.780* 30.09 Profit of 1,083 on sale
2025-04-07 SELL -63 16.920* 30.41 Profit of 1,916 on sale
2025-04-04 SELL -90 17.200* 30.56 Profit of 2,751 on sale
2025-03-31 BUY 9 24.490* 30.84
2025-03-19 SELL -18 28.030* 31.21 Profit of 562 on sale
2025-03-14 SELL -54 27.800* 31.36 Profit of 1,693 on sale
2025-03-13 SELL -18 25.950* 31.43 Profit of 566 on sale
2025-03-12 SELL -306 26.620* 31.50 Profit of 9,640 on sale
2025-03-07 SELL -18 26.720* 31.73 Profit of 571 on sale
2025-03-06 SELL -27 26.990* 31.80 Profit of 859 on sale
2025-03-03 SELL -9 25.100* 32.10 Profit of 289 on sale
2025-02-28 SELL -54 25.860* 32.20 Profit of 1,739 on sale
2025-02-26 SELL -9 25.090* 32.45 Profit of 292 on sale
2025-02-25 SELL -27 25.000* 32.57 Profit of 879 on sale
2025-02-18 BUY 45 27.370* 33.14
2025-02-13 BUY 9 28.500* 33.42
2025-02-12 BUY 9 28.000* 33.53
2025-02-11 BUY 27 27.520* 33.65
2025-02-06 BUY 81 30.030* 33.96
2025-01-27 BUY 9 30.500* 34.79
2024-12-30 BUY 45 28.500* 35.40
2024-12-06 BUY 36 34.590* 35.56
2024-12-05 BUY 9 33.560* 35.63
2024-12-04 BUY 45 35.910* 35.62
2024-11-29 BUY 45 34.750* 35.67
2024-11-27 BUY 36 34.100* 35.81
2024-11-26 BUY 9 33.900* 35.90
2024-11-21 BUY 45 32.340* 36.32
2024-11-20 BUY 27 32.240* 36.54
2024-11-18 BUY 108 33.210* 36.98
2024-11-12 BUY 72 36.980* 36.98
2024-11-08 BUY 45 39.940* 36.77
2024-11-07 BUY 135 39.060* 36.60
2024-11-06 BUY 18 38.690* 36.42
2024-10-31 BUY 9 35.530* 36.49
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-11	BUY	124	33.160*	27.74
2025-08-21	SELL	-31	25.980*	27.75 Profit of 860 on sale
2025-07-31	BUY	93	26.690*	27.77
2025-06-30	SELL	-62	26.000*	27.93 Profit of 1,732 on sale
2025-06-25	SELL	-31	26.060*	27.97 Profit of 867 on sale
2025-06-20	SELL	-62	25.550*	28.02 Profit of 1,737 on sale
2025-05-30	BUY	6,715	25.620*	28.21
2025-05-23	BUY	9	25.440*	28.32
2025-05-19	SELL	-9	24.860*	28.40 Profit of 256 on sale
2025-05-15	SELL	-27	25.350*	28.45 Profit of 768 on sale
2025-05-12	SELL	-9	25.160*	28.56 Profit of 257 on sale
2025-05-09	SELL	-9	23.740*	28.60 Profit of 257 on sale
2025-04-30	SELL	-9	26.940*	28.80 Profit of 259 on sale
2025-04-24	SELL	-18	21.520*	28.96 Profit of 521 on sale
2025-04-17	SELL	-9	20.640*	29.40 Profit of 265 on sale
2025-04-15	SELL	-27	20.110*	29.60 Profit of 799 on sale
2025-04-14	SELL	-27	20.060*	29.70 Profit of 802 on sale
2025-04-09	SELL	-36	17.780*	30.09 Profit of 1,083 on sale
2025-04-07	SELL	-63	16.920*	30.41 Profit of 1,916 on sale
2025-04-04	SELL	-90	17.200*	30.56 Profit of 2,751 on sale
2025-03-31	BUY	9	24.490*	30.84
2025-03-19	SELL	-18	28.030*	31.21 Profit of 562 on sale
2025-03-14	SELL	-54	27.800*	31.36 Profit of 1,693 on sale
2025-03-13	SELL	-18	25.950*	31.43 Profit of 566 on sale
2025-03-12	SELL	-306	26.620*	31.50 Profit of 9,640 on sale
2025-03-07	SELL	-18	26.720*	31.73 Profit of 571 on sale
2025-03-06	SELL	-27	26.990*	31.80 Profit of 859 on sale
2025-03-03	SELL	-9	25.100*	32.10 Profit of 289 on sale
2025-02-28	SELL	-54	25.860*	32.20 Profit of 1,739 on sale
2025-02-26	SELL	-9	25.090*	32.45 Profit of 292 on sale
2025-02-25	SELL	-27	25.000*	32.57 Profit of 879 on sale
2025-02-18	BUY	45	27.370*	33.14
2025-02-13	BUY	9	28.500*	33.42
2025-02-12	BUY	9	28.000*	33.53
2025-02-11	BUY	27	27.520*	33.65
2025-02-06	BUY	81	30.030*	33.96
2025-01-27	BUY	9	30.500*	34.79
2024-12-30	BUY	45	28.500*	35.40
2024-12-06	BUY	36	34.590*	35.56
2024-12-05	BUY	9	33.560*	35.63
2024-12-04	BUY	45	35.910*	35.62
2024-11-29	BUY	45	34.750*	35.67
2024-11-27	BUY	36	34.100*	35.81
2024-11-26	BUY	9	33.900*	35.90
2024-11-21	BUY	45	32.340*	36.32
2024-11-20	BUY	27	32.240*	36.54
2024-11-18	BUY	108	33.210*	36.98
2024-11-12	BUY	72	36.980*	36.98
2024-11-08	BUY	45	39.940*	36.77
2024-11-07	BUY	135	39.060*	36.60
2024-11-06	BUY	18	38.690*	36.42
2024-10-31	BUY	9	35.530*	36.49

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CGON

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	169,299	0	327,645	51.7%
2025-09-18	236,356	1	487,925	48.4%
2025-09-17	662,335	697	834,027	79.4%
2025-09-16	514,864	206	623,703	82.5%
2025-09-15	340,321	4	406,069	83.8%
2025-09-12	500,320	357	873,077	57.3%
2025-09-11	430,015	0	2,289,239	18.8%
2025-09-10	310,123	0	542,845	57.1%
2025-09-09	156,331	1,551	230,380	67.9%
2025-09-08	326,419	33	606,906	53.8%
2025-09-05	527,915	1	771,461	68.4%
2025-09-04	394,926	2,396	509,737	77.5%
2025-09-03	262,983	40,888	304,216	86.4%
2025-09-02	101,295	2,788	137,556	73.6%
2025-08-29	86,952	0	109,930	79.1%
2025-08-28	73,639	0	128,912	57.1%
2025-08-27	101,665	0	148,518	68.5%
2025-08-26	296,523	0	359,851	82.4%
2025-08-25	77,495	1,886	108,120	71.7%
2025-08-22	127,950	8,215	185,362	69.0%
2025-08-21	79,914	100	101,370	78.8%
2025-08-20	53,153	0	70,204	75.7%
2025-08-19	74,355	0	82,454	90.2%
2025-08-18	98,535	0	137,790	71.5%
2025-08-15	42,984	0	78,013	55.1%
2025-08-14	82,712	14,532	118,784	69.6%
2025-08-13	86,520	0	269,029	32.2%
2025-08-12	60,067	0	149,062	40.3%
2025-08-11	104,944	0	196,257	53.5%
2025-08-08	83,269	0	159,665	52.2%
2025-08-07	119,711	4	216,070	55.4%
2025-08-06	152,591	65	193,984	78.7%
2025-08-05	286,205	0	306,548	93.4%
2025-08-04	167,042	0	257,256	64.9%
2025-08-01	173,131	0	303,881	57.0%
2025-07-31	171,268	0	326,208	52.5%
2025-07-30	270,432	0	542,556	49.8%
2025-07-29	429,211	0	558,185	76.9%
2025-07-28	207,928	8	536,417	38.8%
2025-07-25	296,220	0	574,019	51.6%
2025-07-24	160,843	222	307,800	52.3%
2025-07-23	231,890	0	561,911	41.3%
2025-07-22	284,980	0	822,188	34.7%
2025-07-21	360,921	100	390,828	92.3%
2025-07-18	541,950	398	662,245	81.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE